Myles A. Brown

Oncology

44 Binney St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 203 publications

CistromeMeta: a large language model powered tool for automated ChIP-seq metadata extraction.

CistromeMeta: a large language model powered tool for automated ChIP-seq metadata extraction.

Journal: Bioinformatics (Oxford, England)

Published: March 08, 2026

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Lack of synergy between AR-targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 27, 2026

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Epigenetic subtypes of high-grade T1 bladder cancer reveal intra-tumor heterogeneity and distinct interactions with tumor microenvironment.

Journal: Theranostics

Published: December 10, 2025

METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation.

METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 11, 2025

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Journal: Research square

Published: September 02, 2025

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

EZH2-TTP-mTORC1 Axis Drives Phenotypic Plasticity and Therapeutic Vulnerability in Lethal Prostate Cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2025

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Journal: Genome medicine

Published: August 18, 2025

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.

Journal: Molecular cell

Published: July 24, 2025

Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.

Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.

Journal: bioRxiv : the preprint server for biology

Published: July 16, 2025

Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.

Super-resolution microscopy reveals distinct epigenetic states regulated by estrogen receptor activity.

Journal: Research square

Published: June 30, 2025

Advanced Analysis of X-ray Fluorescence Measurements of the Interfacial Density of Eu Ions at Liquid-Liquid Interfaces for Solvent Back-Extraction.

Advanced Analysis of X-ray Fluorescence Measurements of the Interfacial Density of Eu Ions at Liquid-Liquid Interfaces for Solvent Back-Extraction.

Journal: The journal of physical chemistry. A

Published: June 12, 2025

Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Lack of synergy between AR targeted therapies and PARP inhibitors in homologous recombination-proficient prostate cancer.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

Showing 1-12 of 203

Last Updated: 09/26/2026